PUBLISHER: The Business Research Company | PRODUCT CODE: 2127592
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127592
A ribonucleic acid (RNA) isolation and enrichment reagents are specialized chemical formulations and kits designed for the extraction, purification, and concentration of RNA molecules from biological samples such as tissues, cells, and blood. These reagents help maintain RNA stability and integrity while removing contaminants, including proteins, DNA, and other cellular materials. A ribonucleic acid (RNA) isolation and enrichment reagents are widely utilized in molecular biology and diagnostic workflows to support accurate gene expression analysis, sequencing, and other RNA-based research applications.
The primary product types of ribonucleic acid (RNA) isolation and enrichment reagents include ribonucleic acid isolation kits and ribonucleic acid enrichment kits. Ribonucleic acid isolation kits refer to products developed to extract and purify RNA from biological samples for research and diagnostic applications. These products are designed for sample types including blood samples, tissue samples, cell samples, microorganism samples, and other sample types, and are available across price ranges including entry-level products below two hundred dollars and mid-range products ranging from two hundred dollars to five hundred dollars. The various applications include research, diagnostics, and therapeutics, and these products are utilized by end-users such as academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and hospitals.
Tariffs are influencing the ribonucleic acid (RNA) isolation and enrichment reagents market by increasing the cost of imported kits, consumables, and specialized laboratory instruments used in molecular biology workflows. This is resulting in higher operational costs and slower adoption across research and diagnostic laboratories, particularly in regions such as Asia-Pacific and Latin America that rely heavily on imported high-quality reagents. Hardware- and consumable-intensive segments, including next generation sequencing workflows, automated extraction platforms, and enrichment kits, are the most affected due to disruptions in global supply chains. However, tariffs are promoting localized manufacturing, regional supplier diversification, and increased investment in domestic biotechnology ecosystems, which may reinforce long-term supply chain resilience and innovation capacity across the market.
The ribonucleic acid (rna) isolation and enrichment reagent market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (rna) isolation and enrichment reagent market statistics, including ribonucleic acid (rna) isolation and enrichment reagent industry global market size, regional shares, competitors with a ribonucleic acid (rna) isolation and enrichment reagent market share, detailed ribonucleic acid (rna) isolation and enrichment reagent market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) isolation and enrichment reagent industry. This ribonucleic acid (rna) isolation and enrichment reagent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ribonucleic acid (RNA) isolation and enrichment reagent market size has grown rapidly in recent years. It will grow from $0.94 billion in 2025 to $1.04 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to rising demand for molecular diagnostics in infectious diseases, increasing adoption of next generation sequencing technologies, growth in academic and clinical genomics research funding, expansion of biobanking and sample preservation infrastructure, early adoption of manual rna extraction methods in laboratories.
The ribonucleic acid (RNA) isolation and enrichment reagent market size is expected to see rapid growth in the next few years. It will grow to $1.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing shift toward automated and high throughput rna isolation systems, rising demand for precision medicine and transcriptomics based drug discovery, growing use of AI driven bioinformatics for rna data interpretation, expansion of personalized medicine and rare disease research programs, increasing integration of lab robotics and digital lab ecosystems. Major trends in the forecast period include increasing adoption of automated rna extraction platforms integrated with laboratory robotics, growing demand for high purity rna isolation kits for next generation sequencing workflows, expansion of low input and single cell rna isolation solutions for advanced genomics research, rising use of magnetic bead based purification technologies for improved yield and scalability, increasing integration of cloud connected laboratory informatics systems for rna workflow optimization.
The increasing genomics research activities are expected to propel the growth of the ribonucleic acid (RNA) isolation and enrichment reagent market going forward. Genomics research activities involve expanding scientific investigations focused on gene sequencing, transcriptomics, RNA analysis, and molecular biology. These activities are increasing due to the growing demand for precision medicine, which depends on comprehensive genetic analysis to develop targeted therapies and personalized treatment approaches. Ribonucleic acid (RNA) isolation and enrichment reagents support genomics research by enabling the extraction and purification of high-quality RNA for sequencing, transcriptomics, and gene expression analysis, improving data accuracy and the reliability of downstream molecular research. For instance, in July 2023, according to a report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, at the end of the first quarter (Q1) 2023, there were 247 gene therapies in Phase II, but this number rose by 5% to reach 260 by the end of the second quarter (Q2), reflecting growing genomics and genetic research activities. Therefore, the increasing genomics research activities are driving the growth of the ribonucleic acid (RNA) isolation and enrichment reagent market.
Major companies operating in the ribonucleic acid (RNA) isolation and enrichment reagents market are emphasizing the development of one-step viral RNA extraction kits to enhance diagnostic speed, improve accuracy, and streamline workflows in infectious disease testing. One-step viral RNA extraction kits are specialized molecular diagnostic solutions designed to rapidly isolate high-quality nucleic acids from clinical samples while reducing processing steps, lowering contamination risks, and eliminating the need for complex equipment. For instance, in September 2025, Xpedite Diagnostics GmbH, a Germany-based biotechnology company, launched SwiftX Virus, a CE-IVD-certified one-step viral RNA extraction kit for human serum and plasma. It is intended for professional diagnostic and point-of-care applications. The kit provides PCR-ready viral RNA and bacterial DNA in just six minutes using proprietary reverse purification technology, removing the need for centrifuges, spin columns, or hazardous solvents. The solution demonstrated 98% sensitivity and 100% specificity across several tropical and vector-borne pathogens, including Dengue, Chikungunya, Yellow Fever, West Nile Virus, and Leptospira, enabling faster and more reliable molecular diagnostics in both clinical and outbreak-response settings.
In January 2023, ALS Limited, an Australia-based testing laboratory company, acquired Invitek Molecular GmbH for an undisclosed amount. Through this acquisition, ALS Limited aimed to reinforce its molecular diagnostics and life sciences capabilities, expand its range of sample preparation and nucleic acid extraction solutions, and increase its footprint in the global biotechnology and clinical testing markets. Invitek Molecular GmbH is a Germany-based provider of nucleic acid isolation kits, molecular diagnostic reagents, sample preparation technologies, and automated purification solutions for research, clinical, and industrial applications.
Major companies operating in the ribonucleic acid (RNA) isolation and enrichment reagent market report are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Cytiva Sweden AB, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, Takara Bio Inc., MP Biomedicals LLC, Analytik Jena GmbH+Co. KG, Macherey-Nagel GmbH & Co. KG, New England Biolabs Inc., Zymo Research Corporation, Bioneer Corporation, Yeasen Biotechnology (Shanghai) Co. Ltd., Tiangen Biotech (Beijing) Co. Ltd., Geneaid Biotech Ltd., HiMedia Laboratories Pvt. Ltd., Norgen Biotek Corp., Vazyme Biotech Co. Ltd., Illumina Inc., 10x Genomics Inc., Covaris LLC
North America was the dominating region in the ribonucleic acid (RNA) isolation and enrichment reagent market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) isolation and enrichment reagent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ribonucleic acid (RNA) isolation and enrichment reagent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ribonucleic acid (RNA) isolation and enrichment reagents market consists of sales of ribonucleic acid (RNA) extraction kits, magnetic bead-based ribonucleic acid (RNA) isolation reagents, spin column ribonucleic acid (RNA) isolation reagents, and trizol-based ribonucleic acid (RNA) extraction reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ribonucleic Acid (RNA) Isolation And Enrichment Reagent Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ribonucleic acid (rna) isolation and enrichment reagent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ribonucleic acid (rna) isolation and enrichment reagent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) isolation and enrichment reagent market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.